Cookstove Replacement for Prevention of ALRI and Low Birthweight in Nepal

Overview

At our field site in southern Nepal, acute respiratory illness (ARI) has been a leading cause of mortality among young children. Besides immunization there is little evidence for effective primary preventive approaches for ARI on a population basis. Low birth weight is highly prevalent in this population as well affecting approximately 30% of live born infants. Low birth weight is a key determinant of neonatal mortality and has also been resistant to cost-effective interventions in resource poor settings. Given the lack of appropriate interventions for poor, rural areas in developing countries and the strong observational association between open burning of biomass fuel sources and ARI in young children and low birth weight, we have designed a community-based randomized trial to determine if reductions in household indoor smoke exposure can reduce the incidence and duration of acute lower respiratory infections in children <36 months of age and low birthweight among newborn infants. Household indoor smoke reduction will be accomplished by replacing the current cook stove in the household with a locally appropriate, inexpensive model that is more efficient and vented to the exterior. In addition, we will assess the impact on respiratory function and symptoms among adults in the household. The project has 2 phases. Phase 1 is a cluster-randomized, community-based, step-wedge trial of cookstove replacement in a rural population of southern Nepal. Households will be randomized to receive replacement of their cook stove with an appropriately designed, efficient stove that is vented to the exterior at different time periods during the course of the study. An initial period of surveillance for ARI and low birth weight will establish a baseline rate for all clusters. This will be followed by the randomized, serial replacements of cook stoves over a 12 month period. Surveillance will continue throughout this period and for an additional 6 -18 months depending on when the stove was replaced. Phase 2 is a individually randomized trial in a subset of households that will receive either the improved biomass stove from phase 1 or a LPG stove and gas. Follow-up for phase 2 will be for 12 months with the same outcomes as phase 1. Measurement of indoor air particulate concentration will be conducted in all households before and after stove replacement. The analysis for both phases will focus on estimating the impact on incidence of ARI in children and low birth weight among live births as a result of stove replacement. Approximately 4200 children 1-35 months of age will be required to observe a minimum 10% reduction in risk of ARI with 90% power in phase 1. Given the expected number of live births to occur in these clusters, we can detect a 50 gram difference in birthweight with over 90% power and a type I error of 5%. Phase 2 will have lower power (total of 1800 households).

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 2014

Detailed Description

See brief summary above

Interventions

  • Other: Improved biomass cookstove with exterior ventilation
    • Improved cookstove design installed in house that is higher efficiency and is vented to the exterior.
  • Other: Phase 2 intervention arm (LPG stove)
    • LPG two burner stove with a 12 month supply of LP gas.

Arms, Groups and Cohorts

  • Experimental: Improved biomass cookstove with exterior ventilation
    • In phase 1, installation of an improved cookstove with ventilation to exterior is the active arm. In phase 2, this improved biomass cookstove is the control arm.
  • No Intervention: Traditional cookstove
    • In phase 1, the control arm is the traditional standard open burning cookstove in house.
  • Experimental: Phase 2 invervention arm (LPG stove)
    • In phase 2 of this project, households are individually randomized to either continuation of the improved biomass stove from phase 1, or a new LPG stove and gas for 12 months.

Clinical Trial Outcome Measures

Primary Measures

  • Incidence of acute lower respiratory illness.
    • Time Frame: <36 months of age
  • Incidence of Low Birthweight
    • Time Frame: All live births

Secondary Measures

  • Incidence of pre-term birth
    • Time Frame: all live births

Participating in This Clinical Trial

Phase 1 Inclusion Criteria:

  • All households with traditional open burning cookstoves in the study area. Exclusion Criteria:

  • Houses with walls of thatch or bamboo Phase 2 Inclusion criteria:

  • households in the phase 1 study area that either participated in phase 1 or are newly eligible household since phase 1 began. Eligible households are those with either a resident married pregnant woman or at least one child less than 24 months of age.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: 36 Months

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Johns Hopkins Bloomberg School of Public Health
  • Collaborator
    • National Institute of Environmental Health Sciences (NIEHS)
  • Provider of Information About this Clinical Study
    • Principal Investigator: James M. Tielsch, Professor – Johns Hopkins Bloomberg School of Public Health
  • Overall Official(s)
    • James M Tielsch, PhD, Principal Investigator, Johns Hopkins Bloomberg School of Public Health

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.